Follow-on biologics have 3 years to change the FDA culture (and that’s just fine)
There’s been lots of good news for biologics lately. Among them: the leadership of the U.S. Food and Drug Administration isn’t leaving. Even when a president wins a second term, there’s typically some turnover in federal offices. This hasn’t happened at the FDA this time around. Craig Wheeler, president and CEO of Momenta, thinks that […]